Clinical Trial Update: Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial compares larotaxel plus cisplatin versus gemcitabine plus cisplatin as first-line therapy for locally advanced or metastatic urotheli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urothelial Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• Larotaxel (larotaxel)

Snippet

Sponsor: Sanofi | Conditions: Urinary Bladder Neoplasms | Phase 3 | Status: COMPLETED